Evolution Wealth Advisors, LLC Astrazeneca PLC Transaction History

Evolution Wealth Advisors, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$54.02 - $63.83 $38,786 - $45,829	-718 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$55.56 - $60.79 $57,893 - $63,343	-1,042 Reduced 59.2%	718 $43,000
Q2 2021 Jul 22, 2021	BUY	$48.42 - $60.18 $726 - $902	15 Added 0.86%	1,760 $105,000
Q1 2021 Apr 20, 2021	BUY	$47.16 - $54.44 $10,893 - $12,575	231 Added 15.26%	1,745 $87,000
Q4 2020 Feb 02, 2021	SELL	$48.52 - $58.02 $312,420 - $373,590	-6,439 Reduced 80.96%	1,514 $76,000
Q3 2020 Oct 15, 2020	BUY	$53.07 - $61.1 $258,026 - $297,068	4,862 Added 157.3%	7,953 $436,000
Q2 2020 Jul 27, 2020	BUY	$43.1 - $55.31 $75,769 - $97,234	1,758 Added 131.88%	3,091 $163,000
Q1 2020 Apr 22, 2020	SELL	$37.79 - $51.33 $11,903 - $16,168	-315 Reduced 19.11%	1,333 $60,000
Q4 2019 Feb 03, 2020	BUY	$42.46 - $50.46 $60,760 - $72,208	1,431 Added 659.45%	1,648 $82,000
Q3 2019 Nov 12, 2019	SELL	$40.12 - $45.47 $40,280 - $45,651	-1,004 Reduced 82.23%	217 $10,000
Q2 2019 Jul 12, 2019	BUY	$37.28 - $41.68 $45,518 - $50,891	1,221 New	1,221 $50,000

1,360

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.